Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis

BACKGROUND: Immune checkpoint inhibitors have shown promise in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) advanced colorectal cancer (CRC) immunotherapy, and many clinical trials have been conducted. OBJECTIVE: To evaluate the efficacy and safety of PD-1/PD-L1 inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuegang, Du, Yuwei, Xue, Chi, Wu, Pei, Du, Nan, Zhu, Guolian, Xu, Huimian, Zhu, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549670/
https://www.ncbi.nlm.nih.gov/pubmed/36217119
http://dx.doi.org/10.1186/s12876-022-02511-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549670/
https://www.ncbi.nlm.nih.gov/pubmed/36217119
http://dx.doi.org/10.1186/s12876-022-02511-7

Ejemplares similares